BioGenex
Stage
Other Investors | AliveAbout BioGenex
BioGenex offers affordable healthcare solutions for improved wellness of humanity. The company is a technology provider in Molecular Pathology and provides total solution for the complete automation of cell and tissue testing. Through its technologies, it enables disease diagnosis at molecular level. Diagnosis at the molecular level (primarily targeting DNA, RNA and protein), affords early and preventive diagnosis of genetic and infectious diseases.
Missing: BioGenex's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: BioGenex's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing BioGenex
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
BioGenex is included in 1 Expert Collection, including Health Monitoring & Diagnostics.
Health Monitoring & Diagnostics
76 items
Companies developing companion diagnostics and technology enabling the development of companion diagnostics. Tagged as #CompanionDx
BioGenex Patents
BioGenex has filed 5 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/3/2014 | 12/29/2020 | Fluid dynamics, Fluid mechanics, Aerodynamics, Microarrays, Molecular biology | Grant |
Application Date | 10/3/2014 |
|---|---|
Grant Date | 12/29/2020 |
Title | |
Related Topics | Fluid dynamics, Fluid mechanics, Aerodynamics, Microarrays, Molecular biology |
Status | Grant |
Latest BioGenex News
Jan 25, 2023
However, the excise duty implementation by the US Government is expected to restrain the market growth. Regional Markets In 2021, North America had the greatest share of the market followed by Europe and the Asia Pacific. The huge proportion of the North American slide stainers market may be attributed to the region's well-developed healthcare system, convenient access to technologically sophisticated instruments, and the presence of major important players. The application of excise tax by the US government is projected to impede market growth throughout the projection period. However, a lack of qualified technicians and product recalls are projected to limit market growth throughout the projection period. Competitor Insights Some of the key players operating in the slide stainers market are Thermo Fisher Scientific (US), Merck Group (Germany), Roche (Switzerland), Hardy Diagnostics (US). General Data Company (US), BioGenex (US), Sakura (Japan), Biocare Medical (US), Agilent (US), and Danaher (US). This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including technology, product, and end-user from 2022-2029. Technology (Revenue, USD Million) Pharmaceutical and Biotechnology Companies
BioGenex Frequently Asked Questions (FAQ)
Where is BioGenex's headquarters?
BioGenex's headquarters is located at 49026 Milmont Drive, Fremont.
What is BioGenex's latest funding round?
BioGenex's latest funding round is Other Investors.
Who are the investors of BioGenex?
Investors of BioGenex include Pacesetter Capital Group.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.